265 related articles for article (PubMed ID: 18925540)
1. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.
Dadke SS; Li HC; Kusari AB; Begum N; Kusari J
Biochem Biophys Res Commun; 2000 Aug; 274(3):583-9. PubMed ID: 10924321
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
5. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
Mooney RA; Kulas DT; Bleyle LA; Novak JS
Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
[TBL] [Abstract][Full Text] [Related]
8. Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression.
Shi K; Ugi S; Shimizu S; Sekine O; Ikeda K; Egawa K; Yoshizaki T; Nagai Y; Nishio Y; Takada T; Torii R; Kimura H; Kashiwagi A; Maegawa H
Biochem Biophys Res Commun; 2007 Nov; 363(3):626-32. PubMed ID: 17897622
[TBL] [Abstract][Full Text] [Related]
9. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts.
Ide R; Maegawa H; Kikkawa R; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1994 May; 201(1):71-7. PubMed ID: 8198614
[TBL] [Abstract][Full Text] [Related]
10. Knock-down of LAR protein tyrosine phosphatase induces insulin resistance.
Mander A; Hodgkinson CP; Sale GJ
FEBS Lett; 2005 Jun; 579(14):3024-8. PubMed ID: 15896785
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell-based drug screening model for identifying down-regulators of Protein Tyrosine Phosphatase 1B expression.
Lian JH; Guo L; Hu WR; Wu GL; Ji W; Gong BQ
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):24-8. PubMed ID: 17286230
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the insulin receptor with the receptor-like protein tyrosine phosphatases PTPalpha and PTPepsilon in living cells.
Lacasa D; Boute N; Issad T
Mol Pharmacol; 2005 Apr; 67(4):1206-13. PubMed ID: 15630078
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
Li S; Depetris RS; Barford D; Chernoff J; Hubbard SR
Structure; 2005 Nov; 13(11):1643-51. PubMed ID: 16271887
[TBL] [Abstract][Full Text] [Related]
15. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.
Ahmad F; Considine RV; Goldstein BJ
J Clin Invest; 1995 Jun; 95(6):2806-12. PubMed ID: 7769120
[TBL] [Abstract][Full Text] [Related]
16. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
[TBL] [Abstract][Full Text] [Related]
17. Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity.
Wu X; Hoffstedt J; Deeb W; Singh R; Sedkova N; Zilbering A; Zhu L; Park PK; Arner P; Goldstein BJ
J Clin Endocrinol Metab; 2001 Dec; 86(12):5973-80. PubMed ID: 11739472
[TBL] [Abstract][Full Text] [Related]
18. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
Zhang WR; Li PM; Oswald MA; Goldstein BJ
Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).
Holden RJ; Pakula IS; Mooney PA
Med Hypotheses; 1999 Apr; 52(4):319-23. PubMed ID: 10465670
[TBL] [Abstract][Full Text] [Related]
20. Insulin-inducible changes in the relative ratio of PTP1B splice variants.
Sell SM; Reese D
Mol Genet Metab; 1999 Mar; 66(3):189-92. PubMed ID: 10066387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]